C-T variant in a miRNA target site of BCL2 is associated with increased risk of human papilloma virus related cervical cancer-An in silico approach

Genomics

Volumn 98, Issue 3, 2011, Pages 189-193

  Reshmi, G ^a   Surya, Ramachandran ^a   Jissa, V T ^a   Babu, P S Saneesh ^a   Preethi, N R ^a   Santhi, W S ^a   Jayaprakash, P G ^b   Pillai, M Radhakrishna ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^b REGIONAL CANCER CENTRE   (India)

Author keywords

B cell CLL lymphoma 2 (BCL2) ; Cervical Intraepithelial Neoplasia (CIN); Human Papilloma Virus (HPV); MicroRNAs; Single nucleotide polymorphism; Un translated region

Indexed keywords

MICRORNA; PROTEIN BCL 2;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER RISK; CANCER TISSUE; CARCINOGENESIS; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CARCINOMA; WART VIRUS;

3' UNTRANSLATED REGIONS; ALLELES; AMINO ACID SEQUENCE; BINDING SITES; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HELA CELLS; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PAPILLOMAVIRIDAE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-BCL-2; SEQUENCE ALIGNMENT; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 80052154996     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2011.06.005     Document Type: Article

References (29)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94:153-156.
2. Bosch F.X., de Sanjose S. Human papillomavirus and cervical cancer-burden and assessment of causality. J. Natl. Cancer Inst. Monogr. 2003, 31:3-13.
3. WHO Genital human papillomavirus infections and cancer: memorandum from a WHO meeting. Bull 1987, 65:817-827. WHO.
4. Parkin D.M., LSarS E., Muir C.S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer 1990, 4:84-197.
5. Brennecke J., Hipfner D.R., Stark A., Russell R.B., Cohen S.M. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003, 113:25-36.
6. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
7. Reshmi G., Radhakrishna P.M. Beyond HPV: oncomirs as new players in cervical cancer. FEBS Lett. 2008, 582:4113-4116.
8. Wang Xiaohong, et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008, 3(7):e2557.
9. Lee Jeong-Won, et al. Altered microRNA expression in cervical carcinomas. Clin. Cancer Res. 2008, 14(9):2535-2542.
10. Landi Debora, et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008, 29:579-584.
11. Bernig T., Chanock S.J. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev. Mol. Diagn. 2006, 6:319-331.
12. Zhenbao Yu., et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res. 2007, 35:4535-4541.
13. Hansen T., et al. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2007, 2:e873.
14. Chen K., Rajewsky N. Natural selection on human microRNA binding sites inferred from SNP data. Nat. Genet. 2006, 38:1452-1456.
15. Saunders M.A., Han Liang, Li Wen-Hsiung Human polymorphism at microRNAs and microRNA target sites. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3300-3305.
16. Hofacker W., Fontana P.F., Stadler S., Bonhoeffer M., Tacker P., Schuster Fast folding and comparison of RNA condary structures. Monatsh. Chem. 1994, 125:167-188.
17. Ji Qing, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumor spheres. BMC Cancer 2008, 8:266.
18. Ji Qing, Lawrence Theodore S., Xu Liang, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 2009, 4(8):e6816.
19. Radhakrishna P.M., et al. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol. Biomarkers Prev. 1996, 5:329-335.
20. Youle Richard J., Strasser Andreas The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
21. Makoto Saegusa M.D., Yasuo Takano M.D., Miki Hashimura B., Shoji Youko, Okayasu Isao The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer 1995, 76:11.
22. de Villiers E.M. Laboratory techniques in the investigations of human papillomavirus. Genitourin. Med. 1992, 68:50-54.
23. Vinod Chandra S.S., Reshmi G., Sreenadhan S., Radhakrishna Pillai M., Nair S.Achuthsankar MTar: computational microRNA target prediction architecture for human transcriptome. BMC Bioinformatics 2010, 11(Suppl. 1):S2.
24. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
25. Kiriakidou M., et al. A combined computational experimental approach predicts human microRNA targets. Genes Dev. 2004, 18:1165-1178.
26. Betel D., Wilson M., Gabow A., Marks D.S., Chris S. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:D149-D153.
27. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human microRNA targets. PLoS Biol. 2005, 3:264.
28. Pesole G., et al. UTRdb and UTRsite: specialized databases of sequences and functional elements of 5′ and 3′ untranslated regions of eukaryotic mRNAs. Nucleic Acids Res. 2002, 30:335-340.
29. Hariharan R., Babu Janki Mohan, Rema P., Pillai M.Radhakrishna Mutational analysis of Smad7 in human cervical cancer. Oncol. Rep. 2009, 21(4):1001-1004.